AKT1 and intrahepatic cholangiocarcinoma: AKT/YAP S127A ICC mice treated with BEZ235, JQ1 or a combination of BEZ235 and JQ1, as shown in Fig. 6A, were sacrificed 2 days after the last dose of JQ1 or BEZ235 administration.